Effects of aging and gonadal failure on the hypothalamic-pituitary axis in women

N. Santoro, T. Banwell, D. Tortoriello, Harry J. Lieman, T. Adel, J. Skurnick, M. R. Soules, C. B. Hammond, R. C. Stickler, J. E. Buster, R. A. Wild

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

OBJECTIVE: Our aim was to determine the effect of aging on the hypothalamic-pituitary-gonadal axis function. STUDY DESIGN: We studied 9 women aged 25 to 40 years with well-defined idiopathic premature ovarian failure and compared them with 8 women aged 51 to 70 years who had age- appropriate menopause. All women underwent 24 hours of frequent blood sampling every 10 minutes before and after replacement with transdermal estradiol targeted to achieve serum concentrations of approximately 100 pg/ml. RESULTS: In the absence of estrogen exposure, women with premature ovarian failure demonstrated a greater 24-hour mean luteinizing hormone concentration compared with that in the older women with age-appropriate menopause (32.3 ± 4.3 mlU/ml vs 19.2 ± 2.4 mlU/ml, p = 0.0001). Despite the lesser luteinizing hormone serum levels in the older group, the luteinizing hormone pulse frequency per 24 hours was similar (22.1 ± 3.0 pulses per 24 hours in prematurely menopausal women vs 21.9 ± 2.5 pulses per 24 hours in the older postmenopausal women, p = 0.94). When exposed to estrogen, mean luteinizing hormone concentrations decreased to 11.6 ± 2.7 mlU/ml in prematurely menopausal women versus 4.4 ± 1.0 mlU/ml in older postmenopausal women, p = 0.017. Both groups had suppressed mean luteinizing hormone secretion compared with their paired, non-estradiol-exposed studies, p = 0.0001. Frequency of luteinizing hormone pulsations was reduced to 16.5 ± 3.5 pulses per 24 hours in prematurely menopausal women exposed to estradiol (p < 0.0058, compared with non-estradiol-exposed women). Further reduction was observed in older postmenopausal women (11.5 ± 1.1 pulses per 24 hours, p = 0.0001, compared with nonestradiol exposure, and p = 0.0125, vs prematurely menopausal, estradiol-exposed women). Pulse amplitude was suppressed in both prematurely menopausal women (5.6 ± 0.5 mlU/ml to 2.3 ± 0.5 mlU/ml, p = 0.0001) and older postmenopausal women (3.6 ± 0.4 mlU/ml to 2.3 ± 0.6 mlU/ml p = 0.04) in the presence of estradiol. Although luteinizing hormone pulse amplitudes were greater in the women with premature menopause in the absence of estradiol (p = 0.0028) compared with those in older postmenopausal women, pulse amplitudes became similar in the presence of estradiol. Parallel changes in mean follicle-stimulating hormone were observed. Women with premature ovarian failure had a mean follicle- stimulating hormone level of 71.1 ± 9.4 mlU/ml that was suppressed to 18.0 ± 4.1 mlU/ml after estradiol exposure (p = 0.0001); values in older postmenopausal women were 45.9 ± 6.0 and 10.3 ± 2.0, respectively (p = 0.0001). Although the women with premature ovarian failure secreted more follicle-stimulating hormone in the absence and presence of estradiol, only the former situation was statistically significant (p = 0.0008 and p = 0.23, respectively). CONCLUSIONS: These data suggest that there is an age-related decrease in gonadotropin secretion that may be hypothalamic or pituitary in origin. There is less luteinizing hormone secreted in women older than age 50. There is greater suppression of luteinizing hormone and follicle- stimulating hormone secretion by estradiol in aged women. Thus these data indicate that postmenopausal hormone changes involve central hypothalamic- pituitary alterations, as well as ovarian changes.

Original languageEnglish (US)
Pages (from-to)732-741
Number of pages10
JournalAmerican Journal of Obstetrics and Gynecology
Volume178
Issue number4
DOIs
StatePublished - 1998
Externally publishedYes

Fingerprint

Luteinizing Hormone
Estradiol
Primary Ovarian Insufficiency
Follicle Stimulating Hormone
Menopause
Estrogens
Premature Menopause
Serum
Gonadotropins
Hormones

Keywords

  • Aging
  • Endocrinology
  • Hormones
  • Menopause
  • Reproduction

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Effects of aging and gonadal failure on the hypothalamic-pituitary axis in women. / Santoro, N.; Banwell, T.; Tortoriello, D.; Lieman, Harry J.; Adel, T.; Skurnick, J.; Soules, M. R.; Hammond, C. B.; Stickler, R. C.; Buster, J. E.; Wild, R. A.

In: American Journal of Obstetrics and Gynecology, Vol. 178, No. 4, 1998, p. 732-741.

Research output: Contribution to journalArticle

Santoro, N, Banwell, T, Tortoriello, D, Lieman, HJ, Adel, T, Skurnick, J, Soules, MR, Hammond, CB, Stickler, RC, Buster, JE & Wild, RA 1998, 'Effects of aging and gonadal failure on the hypothalamic-pituitary axis in women', American Journal of Obstetrics and Gynecology, vol. 178, no. 4, pp. 732-741. https://doi.org/10.1016/S0002-9378(98)70483-1
Santoro, N. ; Banwell, T. ; Tortoriello, D. ; Lieman, Harry J. ; Adel, T. ; Skurnick, J. ; Soules, M. R. ; Hammond, C. B. ; Stickler, R. C. ; Buster, J. E. ; Wild, R. A. / Effects of aging and gonadal failure on the hypothalamic-pituitary axis in women. In: American Journal of Obstetrics and Gynecology. 1998 ; Vol. 178, No. 4. pp. 732-741.
@article{7d9fb6696ddf40cdbadd88aa4d7537ad,
title = "Effects of aging and gonadal failure on the hypothalamic-pituitary axis in women",
abstract = "OBJECTIVE: Our aim was to determine the effect of aging on the hypothalamic-pituitary-gonadal axis function. STUDY DESIGN: We studied 9 women aged 25 to 40 years with well-defined idiopathic premature ovarian failure and compared them with 8 women aged 51 to 70 years who had age- appropriate menopause. All women underwent 24 hours of frequent blood sampling every 10 minutes before and after replacement with transdermal estradiol targeted to achieve serum concentrations of approximately 100 pg/ml. RESULTS: In the absence of estrogen exposure, women with premature ovarian failure demonstrated a greater 24-hour mean luteinizing hormone concentration compared with that in the older women with age-appropriate menopause (32.3 ± 4.3 mlU/ml vs 19.2 ± 2.4 mlU/ml, p = 0.0001). Despite the lesser luteinizing hormone serum levels in the older group, the luteinizing hormone pulse frequency per 24 hours was similar (22.1 ± 3.0 pulses per 24 hours in prematurely menopausal women vs 21.9 ± 2.5 pulses per 24 hours in the older postmenopausal women, p = 0.94). When exposed to estrogen, mean luteinizing hormone concentrations decreased to 11.6 ± 2.7 mlU/ml in prematurely menopausal women versus 4.4 ± 1.0 mlU/ml in older postmenopausal women, p = 0.017. Both groups had suppressed mean luteinizing hormone secretion compared with their paired, non-estradiol-exposed studies, p = 0.0001. Frequency of luteinizing hormone pulsations was reduced to 16.5 ± 3.5 pulses per 24 hours in prematurely menopausal women exposed to estradiol (p < 0.0058, compared with non-estradiol-exposed women). Further reduction was observed in older postmenopausal women (11.5 ± 1.1 pulses per 24 hours, p = 0.0001, compared with nonestradiol exposure, and p = 0.0125, vs prematurely menopausal, estradiol-exposed women). Pulse amplitude was suppressed in both prematurely menopausal women (5.6 ± 0.5 mlU/ml to 2.3 ± 0.5 mlU/ml, p = 0.0001) and older postmenopausal women (3.6 ± 0.4 mlU/ml to 2.3 ± 0.6 mlU/ml p = 0.04) in the presence of estradiol. Although luteinizing hormone pulse amplitudes were greater in the women with premature menopause in the absence of estradiol (p = 0.0028) compared with those in older postmenopausal women, pulse amplitudes became similar in the presence of estradiol. Parallel changes in mean follicle-stimulating hormone were observed. Women with premature ovarian failure had a mean follicle- stimulating hormone level of 71.1 ± 9.4 mlU/ml that was suppressed to 18.0 ± 4.1 mlU/ml after estradiol exposure (p = 0.0001); values in older postmenopausal women were 45.9 ± 6.0 and 10.3 ± 2.0, respectively (p = 0.0001). Although the women with premature ovarian failure secreted more follicle-stimulating hormone in the absence and presence of estradiol, only the former situation was statistically significant (p = 0.0008 and p = 0.23, respectively). CONCLUSIONS: These data suggest that there is an age-related decrease in gonadotropin secretion that may be hypothalamic or pituitary in origin. There is less luteinizing hormone secreted in women older than age 50. There is greater suppression of luteinizing hormone and follicle- stimulating hormone secretion by estradiol in aged women. Thus these data indicate that postmenopausal hormone changes involve central hypothalamic- pituitary alterations, as well as ovarian changes.",
keywords = "Aging, Endocrinology, Hormones, Menopause, Reproduction",
author = "N. Santoro and T. Banwell and D. Tortoriello and Lieman, {Harry J.} and T. Adel and J. Skurnick and Soules, {M. R.} and Hammond, {C. B.} and Stickler, {R. C.} and Buster, {J. E.} and Wild, {R. A.}",
year = "1998",
doi = "10.1016/S0002-9378(98)70483-1",
language = "English (US)",
volume = "178",
pages = "732--741",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Effects of aging and gonadal failure on the hypothalamic-pituitary axis in women

AU - Santoro, N.

AU - Banwell, T.

AU - Tortoriello, D.

AU - Lieman, Harry J.

AU - Adel, T.

AU - Skurnick, J.

AU - Soules, M. R.

AU - Hammond, C. B.

AU - Stickler, R. C.

AU - Buster, J. E.

AU - Wild, R. A.

PY - 1998

Y1 - 1998

N2 - OBJECTIVE: Our aim was to determine the effect of aging on the hypothalamic-pituitary-gonadal axis function. STUDY DESIGN: We studied 9 women aged 25 to 40 years with well-defined idiopathic premature ovarian failure and compared them with 8 women aged 51 to 70 years who had age- appropriate menopause. All women underwent 24 hours of frequent blood sampling every 10 minutes before and after replacement with transdermal estradiol targeted to achieve serum concentrations of approximately 100 pg/ml. RESULTS: In the absence of estrogen exposure, women with premature ovarian failure demonstrated a greater 24-hour mean luteinizing hormone concentration compared with that in the older women with age-appropriate menopause (32.3 ± 4.3 mlU/ml vs 19.2 ± 2.4 mlU/ml, p = 0.0001). Despite the lesser luteinizing hormone serum levels in the older group, the luteinizing hormone pulse frequency per 24 hours was similar (22.1 ± 3.0 pulses per 24 hours in prematurely menopausal women vs 21.9 ± 2.5 pulses per 24 hours in the older postmenopausal women, p = 0.94). When exposed to estrogen, mean luteinizing hormone concentrations decreased to 11.6 ± 2.7 mlU/ml in prematurely menopausal women versus 4.4 ± 1.0 mlU/ml in older postmenopausal women, p = 0.017. Both groups had suppressed mean luteinizing hormone secretion compared with their paired, non-estradiol-exposed studies, p = 0.0001. Frequency of luteinizing hormone pulsations was reduced to 16.5 ± 3.5 pulses per 24 hours in prematurely menopausal women exposed to estradiol (p < 0.0058, compared with non-estradiol-exposed women). Further reduction was observed in older postmenopausal women (11.5 ± 1.1 pulses per 24 hours, p = 0.0001, compared with nonestradiol exposure, and p = 0.0125, vs prematurely menopausal, estradiol-exposed women). Pulse amplitude was suppressed in both prematurely menopausal women (5.6 ± 0.5 mlU/ml to 2.3 ± 0.5 mlU/ml, p = 0.0001) and older postmenopausal women (3.6 ± 0.4 mlU/ml to 2.3 ± 0.6 mlU/ml p = 0.04) in the presence of estradiol. Although luteinizing hormone pulse amplitudes were greater in the women with premature menopause in the absence of estradiol (p = 0.0028) compared with those in older postmenopausal women, pulse amplitudes became similar in the presence of estradiol. Parallel changes in mean follicle-stimulating hormone were observed. Women with premature ovarian failure had a mean follicle- stimulating hormone level of 71.1 ± 9.4 mlU/ml that was suppressed to 18.0 ± 4.1 mlU/ml after estradiol exposure (p = 0.0001); values in older postmenopausal women were 45.9 ± 6.0 and 10.3 ± 2.0, respectively (p = 0.0001). Although the women with premature ovarian failure secreted more follicle-stimulating hormone in the absence and presence of estradiol, only the former situation was statistically significant (p = 0.0008 and p = 0.23, respectively). CONCLUSIONS: These data suggest that there is an age-related decrease in gonadotropin secretion that may be hypothalamic or pituitary in origin. There is less luteinizing hormone secreted in women older than age 50. There is greater suppression of luteinizing hormone and follicle- stimulating hormone secretion by estradiol in aged women. Thus these data indicate that postmenopausal hormone changes involve central hypothalamic- pituitary alterations, as well as ovarian changes.

AB - OBJECTIVE: Our aim was to determine the effect of aging on the hypothalamic-pituitary-gonadal axis function. STUDY DESIGN: We studied 9 women aged 25 to 40 years with well-defined idiopathic premature ovarian failure and compared them with 8 women aged 51 to 70 years who had age- appropriate menopause. All women underwent 24 hours of frequent blood sampling every 10 minutes before and after replacement with transdermal estradiol targeted to achieve serum concentrations of approximately 100 pg/ml. RESULTS: In the absence of estrogen exposure, women with premature ovarian failure demonstrated a greater 24-hour mean luteinizing hormone concentration compared with that in the older women with age-appropriate menopause (32.3 ± 4.3 mlU/ml vs 19.2 ± 2.4 mlU/ml, p = 0.0001). Despite the lesser luteinizing hormone serum levels in the older group, the luteinizing hormone pulse frequency per 24 hours was similar (22.1 ± 3.0 pulses per 24 hours in prematurely menopausal women vs 21.9 ± 2.5 pulses per 24 hours in the older postmenopausal women, p = 0.94). When exposed to estrogen, mean luteinizing hormone concentrations decreased to 11.6 ± 2.7 mlU/ml in prematurely menopausal women versus 4.4 ± 1.0 mlU/ml in older postmenopausal women, p = 0.017. Both groups had suppressed mean luteinizing hormone secretion compared with their paired, non-estradiol-exposed studies, p = 0.0001. Frequency of luteinizing hormone pulsations was reduced to 16.5 ± 3.5 pulses per 24 hours in prematurely menopausal women exposed to estradiol (p < 0.0058, compared with non-estradiol-exposed women). Further reduction was observed in older postmenopausal women (11.5 ± 1.1 pulses per 24 hours, p = 0.0001, compared with nonestradiol exposure, and p = 0.0125, vs prematurely menopausal, estradiol-exposed women). Pulse amplitude was suppressed in both prematurely menopausal women (5.6 ± 0.5 mlU/ml to 2.3 ± 0.5 mlU/ml, p = 0.0001) and older postmenopausal women (3.6 ± 0.4 mlU/ml to 2.3 ± 0.6 mlU/ml p = 0.04) in the presence of estradiol. Although luteinizing hormone pulse amplitudes were greater in the women with premature menopause in the absence of estradiol (p = 0.0028) compared with those in older postmenopausal women, pulse amplitudes became similar in the presence of estradiol. Parallel changes in mean follicle-stimulating hormone were observed. Women with premature ovarian failure had a mean follicle- stimulating hormone level of 71.1 ± 9.4 mlU/ml that was suppressed to 18.0 ± 4.1 mlU/ml after estradiol exposure (p = 0.0001); values in older postmenopausal women were 45.9 ± 6.0 and 10.3 ± 2.0, respectively (p = 0.0001). Although the women with premature ovarian failure secreted more follicle-stimulating hormone in the absence and presence of estradiol, only the former situation was statistically significant (p = 0.0008 and p = 0.23, respectively). CONCLUSIONS: These data suggest that there is an age-related decrease in gonadotropin secretion that may be hypothalamic or pituitary in origin. There is less luteinizing hormone secreted in women older than age 50. There is greater suppression of luteinizing hormone and follicle- stimulating hormone secretion by estradiol in aged women. Thus these data indicate that postmenopausal hormone changes involve central hypothalamic- pituitary alterations, as well as ovarian changes.

KW - Aging

KW - Endocrinology

KW - Hormones

KW - Menopause

KW - Reproduction

UR - http://www.scopus.com/inward/record.url?scp=0031957355&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031957355&partnerID=8YFLogxK

U2 - 10.1016/S0002-9378(98)70483-1

DO - 10.1016/S0002-9378(98)70483-1

M3 - Article

C2 - 9579435

AN - SCOPUS:0031957355

VL - 178

SP - 732

EP - 741

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 4

ER -